September 26, 2021
  • September 26, 2021

Eye problems

Global Eye Care Surgical Devices Market 2021-2025: High Incidence Of Eye Diseases And Rising Number Of MI Glaucoma Surgeries Driving Growth – ResearchAndMarkets.com

by on September 16, 2021 0

The ‘Global Eye Care Surgical Devices Market 2021-2025’ report has been added to ResearchAndMarkets.com offer. The Eye Care Surgical Devices Market is expected to grow by $ 3.49 billion in the period 2021-2025, growing at a CAGR of 5.86% The market is driven by the high incidence of eye diseases and the increasing number...

Read More

Global Eye Care Surgical Devices Market 2021-2025: High Incidence Of Eye Diseases And Rising Number Of MI Glaucoma Surgeries Driving Growth – ResearchAndMarkets.com

by on September 16, 2021 0

DUBLIN – (COMMERCIAL THREAD) – The ‘Global Eye Care Surgical Devices Market 2021-2025’ report has been added to ResearchAndMarkets.com offer. The Eye Care Surgical Devices Market is expected to grow by $ 3.49 billion in the period 2021-2025, growing at a CAGR of 5.86% The market is driven by the high incidence of eye...

Read More

MellingMedical and TearLab Agreement Aims to Improve Early Detection of Dry Eye Disease in US Veterans | State

by on September 16, 2021 0

ESCONDIDO, California and ALEXANDRIE, Virginia, September 16, 2021 / PRNewswire / – TearLab Corporation (privately held), a leader in ocular surface diagnostics and MellingMedical, a small business owned by a veteran of CVE Verified Service Disability (SDVOSB), today announced a agreement that will allow physicians to more effectively diagnose dry eye disease (DED) in...

Read More

Stuart Therapeutics, Inc. Announces Completion of Patient Enrollment in Phase 2 Clinical Trial for Dry Eye

by on September 8, 2021 0

STUART, Florida, September 8, 2021 / PRNewswire / – Stuart Therapeutics, Inc. (“Stuart“), a clinical-stage biopharmaceutical company conducting research and development of unique peptide therapies for ophthalmic diseases, today announced that it has completed patient enrollment in its Phase 2 clinical trial to assess the efficacy of its drug candidate ST-100, administered topically to...

Read More